Greg Duncan
2022
In 2022, Greg Duncan earned a total compensation of $936.8K as Chairman and Chief Executive Officer at Virios Therapeutics, a 15% decrease compared to previous year.
Compensation breakdown
| Option Awards | $377,242 |
|---|---|
| Salary | $528,900 |
| Other | $30,690 |
| Total | $936,832 |
Duncan received $528.9K in salary, accounting for 56% of the total pay in 2022.
Duncan also received $377.2K in option awards and $30.7K in other compensation.
Rankings
In 2022, Greg Duncan's compensation ranked 3,144th out of 5,625 executives tracked by ExecPay. In other words, Duncan earned more than 44.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,144 out of 5,625 | 44th |
Division Manufacturing | 1,762 out of 3,053 | 42nd |
Major group Chemicals And Allied Products | 827 out of 1,380 | 40th |
Industry group Drugs | 771 out of 1,281 | 40th |
Industry Pharmaceutical Preparations | 559 out of 927 | 40th |
Source: SEC filing on April 27, 2023.
Duncan's colleagues
We found two more compensation records of executives who worked with Greg Duncan at Virios Therapeutics in 2022.
News
Virios Therapeutics CEO Greg Duncan's 2023 pay falls 39% to $567K
April 25, 2024
Virios Therapeutics CEO Greg Duncan's 2022 pay slips 15% to $937K
April 27, 2023
Virios Therapeutics CEO Greg Duncan's 2021 pay falls 69% to $1.1M
April 26, 2022
Virios Therapeutics CEO Greg Duncan receives $3.5M in 2020
April 28, 2021